Healthcare Strategies

HHS Petitions DEA to Reclassify Cannabis as a Schedule III Drug

September 7, 2023 - On August 30, 2023, a leaked document revealed that the United States Department of Health and Human Services (HHS) plans to petition the Drug Enforcement Administration (DEA) to reclassify cannabis from a Schedule I to a Schedule III drug. Bloomberg broke the news after seeing a document sent to Anne Milgram, head of the DEA, from an official at...

Read More


More Articles

Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products

by Veronica Salib

On April 28, 2022, the FDA placed a total ban on all flavored nicotine products in an attempt to reduce the number of nicotine-related diseases and illnesses. Following previous FDA rulings to ban...

Aid Access Discusses Making Abortion Pill Available as Contraception

by Veronica Salib

In an interview with Democracy Now, Rebecca Gomperts, MD, mentioned plans to make mifepristone, the abortion pill, available as a weekly or emergency contraceptive. Gomperts is the founder of Aid...

COVID-19 Vaccine Dominates 2021 Pharmaceutical Industry Trends

by Emily Sokol, MPH

Future industry-wide trends for pharmaceutical companies and manufacturers are taking root as the industry continues to respond to the COVID-19 pandemic. Listen to the full podcast to hear...

Recent Articles